With its (upsized) $82.875 million dollar financing, Field Trip establishes itself as one of the industry leaders in the psychedelics space.
150x50
VIEW IN BROWSER
Field Trip Health Will Upsize Previously Announced Bought Deal Public Offering!
Underwriters from Bloom Burton Securities Inc have agreed to purchase, on a “bought deal” basis, 12,750,000 common shares of Field Trip? - What Investors Should Know | Find out the details
Mind Cure Strengthens Leadership Team With ANOTHER New Addition
This transition at the director level further enhances the Company's leadership in a few key technology areas. | Find out more
Do You Want Some Psilocybin Truffles?
An agency has been granted authorization to legally import psilocybin truffles! | Read more
32x32x1   32x32x2  
TheSeedInvestor.com
9375 E Shea Blvd Ste 100
Scottsdale 85260
info@theseedinvestor.com
 
©2019, All Rights Reserved  |  Unsubscribe   |   View this in Browser

To keep receiving emails from us, please add us to your address book.